Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt’s Lymphoma or Burkitt’s Leukemia
Condition(s):Leukemia; LymphomaLast Updated:August 21, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Leukemia; LymphomaLast Updated:August 21, 2023Completed
Condition(s):GoutLast Updated:October 3, 2014Completed
Condition(s):Kidney Stones; NephrolithiasisLast Updated:February 1, 2024Recruiting
Condition(s):Liver Transplantation; Transplant RecipientLast Updated:January 6, 2011Completed
Condition(s):GoutLast Updated:April 28, 2017Completed
Condition(s):Acute Gout FlareLast Updated:April 28, 2017Completed
Condition(s):GoutLast Updated:April 10, 2023Recruiting
Condition(s):Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unusual Cancers of ChildhoodLast Updated:September 27, 2017Terminated
Condition(s):Obesity; Chronic Kidney Disease; Metabolic SyndromeLast Updated:April 18, 2011Unknown status
Condition(s):HyperuricemiaLast Updated:August 26, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.